Wang SJ - Search Results

1

[Efficacy and tolerability of the combination of oxaliplatin, ifosfamide, and epirubicin in treatment of recurrent or platinum-resistant ovarian epithelial cancer patients].

Li XP, Cui H, Zhou JW, Wei LH, Wang JL, Zhao Y, Wang Y, Wang SJ, Zhu HL, Dong L, Zhang H. Li XP, et al. Among authors: wang jl, wang y, wang sj. Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):724-7. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19087535 Clinical Trial. Chinese.

2

[Clinical management and prognostic analysis of primary peritoneal neoplasms].

Zhang C, Cui H, Zhao Y, Liang XD, Wang CH, Li XP, Shen DH, Wang SJ, Wei LH. Zhang C, et al. Among authors: wang ch, wang sj. Zhonghua Fu Chan Ke Za Zhi. 2005 Jul;40(7):464-8. Zhonghua Fu Chan Ke Za Zhi. 2005. PMID: 16080873 Chinese.

3

[Evaluation of transposed ovarian function in young women with cervical cancer].

Wang JL, Zhang XH, Liang XD, Wang SJ, Xing HM, Wei LH. Wang JL, et al. Among authors: wang sj. Zhonghua Fu Chan Ke Za Zhi. 2006 Apr;41(4):229-32. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 16759455 Chinese.

4

[Clinical analysis of 225 women with congenital uterine malformation].

Wang SJ, Oli M, Jinag L, Wang JL, Wei LH. Wang SJ, et al. Among authors: wang jl. Zhonghua Fu Chan Ke Za Zhi. 2008 Jul;43(7):493-6. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19080510 Chinese.

5

[Profiling of serum tumor markers in patients with epithelial ovarian carcinoma].

Dong L, Li XP, Cui H, Wang JL, Wei LH, Zhao Y, Wang SJ, Wang Y, Sun XL, Liang XD, Li Y. Dong L, et al. Among authors: wang jl, wang y, wang sj. Zhonghua Fu Chan Ke Za Zhi. 2009 Feb;44(2):121-5. Zhonghua Fu Chan Ke Za Zhi. 2009. PMID: 19570423 Chinese.

6

The changes in residual cancer burden after interval debulking surgery are effective in evaluating the response to adjuvant chemotherapy.

Kong L, Li X, Xu Q, Wei L, Wang J, Cui H, Wang S, Zhao Y. Kong L, et al. Chemotherapy. 2011;57(3):209-16. doi: 10.1159/000323625. Epub 2011 May 9. Chemotherapy. 2011. PMID: 21555882

7

Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.

Wang Y, Wang G, Wei LH, Huang LH, Wang JL, Wang SJ, Li XP, Shen DH, Bao DM, Gao J. Wang Y, et al. Among authors: wang g, wang jl, wang sj. Chin J Cancer. 2011 Sep;30(9):645-54. doi: 10.5732/cjc.011.10050. Chin J Cancer. 2011. PMID: 21880186 Free PMC article.

8

Evaluation of whether serum tumor markers in patients with epithelial ovarian carcinoma change following chemotherapy.

Li XP, Xu QY, Wang JL, Wang SJ, Zhao Y, Wei LH. Li XP, et al. Among authors: wang jl, wang sj. Chin Med J (Engl). 2012 Feb;125(3):410-5. Chin Med J (Engl). 2012. PMID: 22490394

9

[Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].

Mu T, Li XP, Wang JL, Wang SJ, Wang Y, Sun XL, Cui H, Wei LH. Mu T, et al. Among authors: wang jl, wang y, wang sj. Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):566-70. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 23141174 Chinese.

10

Oxaliplatin-based combination chemotherapy is still effective for the treatment of recurrent and platinum-resistant epithelial ovarian cancer: results from a single center.

Zhang G, Li XP, Liu BJ, Wang JL, Wang SJ, Cui H, Wei LH. Zhang G, et al. Among authors: wang jl, wang sj. Chin Med J (Engl). 2013 Dec;126(23):4477-82. Chin Med J (Engl). 2013. PMID: 24286410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,311 results

Search Page

Filters